← Research library

The drug Hypoxen: a new inhibitor of mitochondrial respiration and dehydrogenases

Lab research · 2010

What was studied
Isolated rat liver mitochondria
Main finding
Hypoxen reduced phosphorylating and uncoupled respiration, with substrate-dependent concentration thresholds. Malate, glutamate and succinate dehydrogenase activities decreased. This qualifies the claim that it uniformly increases mitochondrial respiration.

Study data at a glance

Participants or experimental model
Isolated rat liver mitochondria
Reported results
Hypoxen reduced phosphorylating and uncoupled respiration, with substrate-dependent concentration thresholds. Malate, glutamate and succinate dehydrogenase activities decreased. This qualifies the claim that it uniformly increases mitochondrial respiration.
Study limitations and source details

Study limitations

  • Isolated organelles and experimental concentrations do not establish effects of oral use in humans.
  • The translation and Russian paper are the same experiment.

Source details

Journal article

Indexed or publisher abstract reviewed; full methods and risk of bias not appraised.

Abstract reviewed

Sources checked

Citation

In vitroEnglish abstract

E. A. Kosenko, M. B. Abramova, N. I. Venediktova, I. I. Popova, Yu. G. Kaminskii. The drug Hypoxen: a new inhibitor of mitochondrial respiration and dehydrogenases Izv Akad Nauk Ser Biol. (4):411–416; English translation Biology Bulletin 37:346–350

Study source ↗ · DOI 10.1134/S1062359010040035 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards